DK0979083T3 - Anvendelse af 1-ar(alk)yl-imidazolin-2-oner til behandling af angst- og stresstilstande - Google Patents

Anvendelse af 1-ar(alk)yl-imidazolin-2-oner til behandling af angst- og stresstilstande

Info

Publication number
DK0979083T3
DK0979083T3 DK98933532T DK98933532T DK0979083T3 DK 0979083 T3 DK0979083 T3 DK 0979083T3 DK 98933532 T DK98933532 T DK 98933532T DK 98933532 T DK98933532 T DK 98933532T DK 0979083 T3 DK0979083 T3 DK 0979083T3
Authority
DK
Denmark
Prior art keywords
imidazolin
alk
anxiety
ones
treatment
Prior art date
Application number
DK98933532T
Other languages
Danish (da)
English (en)
Inventor
Chris Rundfeldt
Reni Bartsch
Rita Dost
Christine Tober
Angelika Rostock
Klaus Unverferth
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Application granted granted Critical
Publication of DK0979083T3 publication Critical patent/DK0979083T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98933532T 1997-05-23 1998-05-14 Anvendelse af 1-ar(alk)yl-imidazolin-2-oner til behandling af angst- og stresstilstande DK0979083T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19721580A DE19721580A1 (de) 1997-05-23 1997-05-23 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
PCT/DE1998/001343 WO1998052548A2 (fr) 1997-05-23 1998-05-14 Utilisation de 1-ar(alk)yl-imidazolin-2-one pour le traitement de l'angoisse et du stress
US09/079,802 US5994347A (en) 1997-05-23 1998-05-15 For a process for treatment of anxiety and tension

Publications (1)

Publication Number Publication Date
DK0979083T3 true DK0979083T3 (da) 2003-12-01

Family

ID=26036759

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98933532T DK0979083T3 (da) 1997-05-23 1998-05-14 Anvendelse af 1-ar(alk)yl-imidazolin-2-oner til behandling af angst- og stresstilstande

Country Status (25)

Country Link
US (1) US5994347A (fr)
EP (1) EP0979083B1 (fr)
JP (1) JP4838403B2 (fr)
CN (1) CN1150901C (fr)
AR (1) AR012746A1 (fr)
AT (1) ATE246926T1 (fr)
AU (1) AU745536B2 (fr)
BG (1) BG63378B1 (fr)
BR (1) BR9809666A (fr)
CA (1) CA2291075C (fr)
DE (2) DE19721580A1 (fr)
DK (1) DK0979083T3 (fr)
ES (1) ES2205516T3 (fr)
HU (1) HUP0003108A3 (fr)
IL (1) IL132652A0 (fr)
NO (1) NO325346B1 (fr)
NZ (1) NZ500849A (fr)
PL (1) PL193589B1 (fr)
PT (1) PT979083E (fr)
RU (1) RU2203055C2 (fr)
SK (1) SK284258B6 (fr)
TR (1) TR199902815T2 (fr)
TW (1) TW579294B (fr)
WO (1) WO1998052548A2 (fr)
ZA (1) ZA984197B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
RU2354377C2 (ru) * 2003-07-11 2009-05-10 Берингер Ингельхайм Ветмедика Гмбх Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора
US8101208B2 (en) 2004-08-11 2012-01-24 Kraft Foods Global Brands Llc Sensate compositions and delivery systems therefor
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
RU94027048A (ru) * 1994-07-18 1996-05-20 Иркутский институт органической химии СО РАН Анксиолитическое средство
US5869481A (en) * 1995-09-05 1999-02-09 Arzneitmittelwerk Dresden G.M.B.H. Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
DE19532668A1 (de) * 1995-09-05 1997-03-06 Dresden Arzneimittel Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
WO1998052548A3 (fr) 1999-04-22
ZA984197B (en) 1998-06-24
DE59809285D1 (de) 2003-09-18
DE19721580A1 (de) 1998-11-26
US5994347A (en) 1999-11-30
AU745536B2 (en) 2002-03-21
ES2205516T3 (es) 2004-05-01
TW579294B (en) 2004-03-11
WO1998052548A2 (fr) 1998-11-26
BG63378B1 (bg) 2001-12-29
JP2001525829A (ja) 2001-12-11
EP0979083A2 (fr) 2000-02-16
SK284258B6 (sk) 2004-12-01
EP0979083B1 (fr) 2003-08-13
NO995300L (no) 1999-10-29
PT979083E (pt) 2003-12-31
CA2291075C (fr) 2006-04-04
PL193589B1 (pl) 2007-02-28
NO325346B1 (no) 2008-04-07
NO995300D0 (no) 1999-10-29
CA2291075A1 (fr) 1998-11-26
IL132652A0 (en) 2001-03-19
AU8332698A (en) 1998-12-11
HUP0003108A3 (en) 2001-07-30
NZ500849A (en) 2001-09-28
JP4838403B2 (ja) 2011-12-14
ATE246926T1 (de) 2003-08-15
TR199902815T2 (xx) 2000-08-21
BR9809666A (pt) 2000-07-11
SK158499A3 (en) 2001-03-12
CN1260717A (zh) 2000-07-19
RU2203055C2 (ru) 2003-04-27
CN1150901C (zh) 2004-05-26
AR012746A1 (es) 2000-11-08
BG103859A (en) 2000-07-31
HUP0003108A2 (hu) 2001-05-28
PL337090A1 (en) 2000-07-31

Similar Documents

Publication Publication Date Title
DK0998473T3 (da) Krystalmodifikation af et N-phenyl-2-pyrimidinaminderivat, fremgangsmåder til fremstilling deraf samt dets anvendelse
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
NO20011084D0 (no) Presisjonsklokkingsgeneratorsystem og fremgangsmÕte ved samme
DE69722293D1 (de) Element zur Abtrennung von Wasserstoff
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
DK1021194T3 (da) Ny forbedret formulering til behandling af osteoporose
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
DE69825327D1 (de) Prüfanordnung und Prüfverfahren
FI972701A7 (fi) Menetelmä päätelaitteiden käytön rajoittamiseksi
DE69720546D1 (de) Kaskadierter Anschluss von kommuniziernden Geräten
DK0961609T3 (da) Fremgangsmåde til forbedring af sundhedstilstanden af hår og hovedbund
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK199800837A (da) Anlæg til behandling af emner
ID22220A (id) Elemen pelekat dengan kulit pengisap
DK0876573T3 (da) Keramisk tænder og fremgangsmåde til anvendelse af samme
DK0777457T3 (da) Anvendelse af glyceryltriacetat til behandling af onychomykoser
NO993298L (no) Ny fremgangsmÕte
NO995796D0 (no) Ny fremgangsmåte
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
DK0979083T3 (da) Anvendelse af 1-ar(alk)yl-imidazolin-2-oner til behandling af angst- og stresstilstande
DK1021200T3 (da) Fremgangsmåder og præparater til behandling af rheumatoid arthritis
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf
DE69813119D1 (de) Optisches Beobachtungssystem und optisches Gerät unter Verwendung desselben
DK1032559T3 (da) Aminoalkylphenolderivater til behandling af depression og hukommelsessvigt